Practice-Relevant Revision of Ipset-Thrombosis Based on 1019 Patients With WHO-Defined Essential Thrombocythemia

Blood - United States
doi 10.1182/blood.v126.23.4055.4055
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential Thrombocythemia

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2019English

The New WHO Classification for Essential Thrombocythemia Calls for Revision of Available Evidences

Blood Cancer Journal
OncologyHematology
2020English

Validation of the IPSET Score for Thrombosis in Patients With Prefibrotic Myelofibrosis

Blood Cancer Journal
OncologyHematology
2020English

ASXL1 Mutations in Chinese Patients With Essential Thrombocythemia

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Essential Thrombocythemia

New England Journal of Medicine
Medicine
2020English

Essential Thrombocythemia

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2007English

Arterial Thrombosis in Thrombocythemia

American Heart Journal
Cardiovascular MedicineCardiology
1993English

Normal Life Expectancy and Thrombosis-Free Survival in Aspirin Treated Essential Thrombocythemia

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
1999English

The Use of Anagrelide in Myeloproliferative Neoplasms, With Focus on Essential Thrombocythemia

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy